MorphoSys develops novel antibodies for therapeutic, diagnostic and research applications. The Company's HuCAL technology is one of the most powerful methods available for generating fully human antibodies. By applying its proprietary technologies, MorphoSys has become a leader in therapeutic antibodies, one of the fastest-growing drug classes in human health-care.
Broadcast live, record and publish your investor, corporate and analyst videos on 3B NEXUS for our targeted distribution. 3bnexus.com